Datar Cancer Genetics
PrivateLast Round
VC Round
Nov 27, 2024
Company Overview
Datar Cancer Genetics is a molecular oncology company that develops non-invasive diagnostic solutions for cancer, including liquid biopsies for early detection, treatment guidance, and monitoring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Datar Cancer Genetics Comparables
Compare Datar Cancer Genetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DiaCarta, Inc. | 82% | |
| CellMax Life | 82% | |
| ClearNote Health | 80% | |
Datar Cancer Genetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 27, 2024 | ||||
| Series A | Aug 26, 2024 |
Datar Cancer Genetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alkemi Growth Capital | VC Round, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 23, 2025
Launched NaturaGene-AI, an advanced oncology testing panel.
- Feb 11, 2025
Dr. Massimo Cristofanilli appointed as Strategic Advisor.
Datar Cancer Genetics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Datar Cancer Genetics's valuation, stock price, and market status.